LUCD – lucid diagnostics inc. (US:NASDAQ)
Stock Stats
News
Lucid Diagnostics Inc. (NASDAQ: LUCD) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $2.50 price target on the stock.
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results [Yahoo! Finance]
Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall [Yahoo! Finance]
Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall
Form 10-Q Lucid Diagnostics Inc. For: Mar 31
Form 3 Lucid Diagnostics Inc. For: May 06 Filed by: Matheis Dennis
Form 4 Lucid Diagnostics Inc. For: May 08 Filed by: Matheis Dennis
Form 4 Lucid Diagnostics Inc. For: May 07 Filed by: O'Neil Shaun
Form 4 Lucid Diagnostics Inc. For: May 07 Filed by: Gordon Michael Adam
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.